Article Text
Letters
Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjögren's syndrome: data from a placebo-controlled clinical trial
Statistics from Altmetric.com
Footnotes
-
Funding Supported by Roche, Woerden, The Netherlands.
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval The ethics committee of the University Medical Center Groningen (METC approval: 05.229).
-
Provenance and peer review Not commissioned; externally peer reviewed.